Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application

被引:155
作者
Fox, BP [1 ]
Kandpal, RP [1 ]
机构
[1] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA
关键词
Eph receptor; ephrin; matrigel invasion; mammary gland development; breast cancer; breast carcinoma cell lines; diagnostic and prognostic markers of breast carcinoma; MCF-10A; MCF-7; MDA-MB-231; expression profile;
D O I
10.1016/j.bbrc.2004.04.102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Eph family of receptors, with 14 members in humans, makes up the largest group of receptor tyrosine kinases. These Eph receptors, along with their ligands, the 8 members of the ephrin family of ligands are involved in diverse developmental functions, including hindbrain development in vertebrates, tissue patterning, and angiogenesis. These Eph receptors and ephrin ligands have also been identified as important regulators in the development and progression of cancer. We have presented here a systematic and comprehensive investigation of the Eph/ephrin expression profiles of MCF-10A, MCF-7, and MDA-MB-231 cells representing normal breast, non-invasive breast tumor, and invasive tumor, respectively, based on their characteristic phenotypes in Matrigel matrix. The data have allowed us to correlate the gene expression profile with the cell phenotype that has potential application in tumor diagnostics. We demonstrate here that upregulation of EphA2, A7, A10, and ephrinA2 and B3 is likely involved in tumorigenesis and/or invasiveness, while downregulation of EphA1, A3, A4, A8, B3, B4, B6, and ephrinA1 and B1 may be particularly important in invasiveness. Based on these results we discuss the role of EphA2 and ephrinA1 combination in malignancy. The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:882 / 892
页数:11
相关论文
共 51 条
  • [1] Vascular patterning by Eph receptor tyrosine kinases and ephrins
    Adams, RH
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2002, 13 (01) : 55 - 60
  • [2] ALBINI A, 1987, CANCER RES, V47, P3239
  • [3] ANDRES AC, 1994, ONCOGENE, V9, P1461
  • [4] Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters
    Bertucci, F
    Salas, S
    Eysteries, S
    Nasser, V
    Finetti, P
    Ginestier, C
    Charafe-Jauffret, E
    Loriod, B
    Bachelart, L
    Montfort, J
    Victorero, G
    Viret, F
    Ollendorff, V
    Fert, V
    Giovaninni, M
    Delpero, JR
    Nguyen, C
    Viens, P
    Monges, G
    Birnbaum, D
    Houlgatte, R
    [J]. ONCOGENE, 2004, 23 (07) : 1377 - 1391
  • [5] Axis of evil: molecular mechanisms of cancer metastasis
    Bogenrieder, T
    Herlyn, M
    [J]. ONCOGENE, 2003, 22 (42) : 6524 - 6536
  • [6] BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS
    CAILLEAU, R
    YOUNG, R
    OLIVE, M
    REEVES, WJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) : 661 - 674
  • [7] The Eph family in the patterning of neural development
    Drescher, U
    [J]. CURRENT BIOLOGY, 1997, 7 (12) : R799 - R807
  • [8] Topographic targeting and pathfinding errors of retinal axons following overexpression of ephrinA ligands on retinal ganglion cell axons
    Dütting, D
    Handwerker, C
    Drescher, U
    [J]. DEVELOPMENTAL BIOLOGY, 1999, 216 (01) : 297 - 311
  • [9] Protein tyrosine kinases in malignant melanoma
    Easty, DJ
    Bennett, DC
    [J]. MELANOMA RESEARCH, 2000, 10 (05) : 401 - 411
  • [10] ABNORMAL PROTEIN-TYROSINE KINASE GENE-EXPRESSION DURING MELANOMA PROGRESSION AND METASTASIS
    EASTY, DJ
    HERLYN, M
    BENNETT, DC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (01) : 129 - 136